SPOTLIGHT -
A study undertaken to evaluate the efficacy and tolerability of single pulse transcranial magnetic stimulation (sTMS) for the preventive treatment of migraine has led to an FDA extended indication.
NeurologyLive® Friday 5 — June 2, 2023
Episode 88: 2023 AAN Annual Meeting Highlights
This Week on NeurologyLive® — May 29, 2023
Episode 67: Mental Health and Advocacy in Pediatric Migraine
NeurologyLive® Friday 5 — May 26, 2023
Research Suggests Connection Between Sex Hormones and CGRP in Migraine Pathophysiology